Skip to main content
. Author manuscript; available in PMC: 2011 May 27.
Published in final edited form as: Cancer. 2008 Feb 15;112(4):789–799. doi: 10.1002/cncr.23244

TABLE 2.

Description of Adjuvant Therapy Received by Stage II and III Rectal Cancer Patients

Total
Stage II
Stage III
No. % No. % No. %
Total 2886 100.0 1524 100.0 1362 100.0
Rates of
 Radiation therapy receipt* 1573 54.5 732 48.0 841 61.8
 Chemotherapy receipt* 1502 52.0 641 42.1 861 63.2
 Both radiation therapy and chemotherapy receipt* 1309 45.4 571 37.5 738 54.2
Among those receiving adjuvant radiation therapy
 Receiving neoadjuvant radiation therapy* 306 19.4 191 26.1 115 13.7
 Initiation of radiation therapy before or within 8 wk of resection* 1006 64.0 509 69.5 497 59.1
Among those receiving adjuvant chemotherapy
 Receiving neoadjuvant chemotherapy* 198 13.2 127 19.8 71 8.2
 Initiation of chemotherapy before or within 8 wk of resection 1176 78.3 483 75.4 693 80.5

All chi-square overall, comparing stage II with stage III with different characteristics of therapy. (No statistics for testing duration of therapy.)

*

P ≤.001.

P ≤.05.